Cargando…
Erratum to: Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial
Autores principales: | Tsai, Tzu-Hsien, Lu, Cheng-Hsien, Wallace, Christopher Glenn, Chang, Wen-Neng, Chen, Shu-Feng, Huang, Chi-Ren, Tsai, Nai-Wen, Lan, Min-Yu, Sung, Pei-Hsun, Liu, Chu-Feng, Yip, Hon-Kan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818475/ https://www.ncbi.nlm.nih.gov/pubmed/27037155 http://dx.doi.org/10.1186/s13054-016-1256-y |
Ejemplares similares
-
Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial
por: Tsai, Tzu-Hsien, et al.
Publicado: (2015) -
Combination of cyclosporine and erythropoietin improves brain infarct size and neurological function in rats after ischemic stroke
por: Yuen, Chun-Man, et al.
Publicado: (2011) -
Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke
por: Yip, Hon-Kan, et al.
Publicado: (2011) -
The Prognostic Values of Leukocyte Rho Kinase Activity in Acute Ischemic Stroke
por: Cheng, Cheng-I., et al.
Publicado: (2014) -
Comparison of acute versus convalescent stage high-sensitivity C-Reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietin
por: Yeh, Kuo-Ho, et al.
Publicado: (2012)